Chronic Pain

The endocannabinoid system and migraine.

Abstract: The recently discovered endocannabinoid system (ECS), which includes endocannabinoids and the proteins that metabolize and bind them, has been…

3 years ago

CBD may counteract the development of experimental multiple sclerosis (MS)

Summary: This study was aimed to investigate whether treatment with purified cannabidiol (CBD) may counteract the development of experimental multiple…

3 years ago

Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain.

Summary: OBJECTIVE: Debilitating pain, occurring in 50-70% of multiple sclerosis (MS) patients, is poorly understood and infrequently studied. We summarized…

3 years ago

Cannabinoids and hallucinogens for headache.

Summary: Hallucinogens and most cannabinoids are classified under schedule 1 of the Federal Controlled Substances Act 1970, along with heroin…

3 years ago

Therapeutic potential of CBD

Summary: Cannabinoid-based drugs modeled on cannabinoids originally isolated from marijuana are now known to significantly impact the functioning of the…

3 years ago

CBDs in the management of difficult to treat pain.

Summary: This article reviews recent research on cannabinoid analgesia via the endocannabinoid system and non-receptor mechanisms, as well as randomized…

3 years ago

CBD is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain.

Summary: Cannabidiol, the major psycho-inactive component of cannabis, has substantial anti-inflammatory and immunomodulatory effects. This study investigated its therapeutic potential…

3 years ago